Docosahexaenoic acid prevents dendritic cell maturation, inhibits antigen-specific Th1/Th17 differentiation and suppresses experimental autoimmune encephalomyelitis

Brain, Behavior, and Immunity

Volumn 25, Issue 5, 2011, Pages 872-882

  Kong, Weimin ^a   Yen, Jui Hung ^a   Ganea, Doina ^a  

^a TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Docosahexaenoic acid; Experimental autoimmune encephalomyelitis; Foxp3; IL 12; IL 23; ROR t; Tbet; Th1; Th17

Indexed keywords

B7 ANTIGEN; CD4 ANTIGEN; CD40 ANTIGEN; CD69 ANTIGEN; CD86 ANTIGEN; CELL NUCLEUS RECEPTOR; CYCLIN DEPENDENT KINASE INHIBITOR 1B; DOCOSAHEXAENOIC ACID; GAMMA INTERFERON; HERMES ANTIGEN; INTERLEUKIN 10; INTERLEUKIN 12P70; INTERLEUKIN 2; INTERLEUKIN 2 RECEPTOR ALPHA; INTERLEUKIN 23; INTERLEUKIN 6; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; POLYUNSATURATED FATTY ACID; RETINOID RELATED ORPHAN RECEPTOR GAMMA; TRANSCRIPTION FACTOR GATA 3; TRANSCRIPTION FACTOR T BET;

ALLERGIC ENCEPHALOMYELITIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN SPECIFICITY; ANTIINFLAMMATORY ACTIVITY; ARTICLE; BONE MARROW CELL; CD4+ T LYMPHOCYTE; CELL MATURATION; CENTRAL NERVOUS SYSTEM; CONTROLLED STUDY; CYTOKINE PRODUCTION; DENDRITIC CELL; LYMPHOCYTE DIFFERENTIATION; MOUSE; MULTIPLE SCLEROSIS; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; T LYMPHOCYTE ACTIVATION; TH1 CELL; TH17 CELL;

ANIMALS; CD4-POSITIVE T-LYMPHOCYTES; CELL DIFFERENTIATION; CELL PROLIFERATION; CELLS, CULTURED; CYTOKINES; DENDRITIC CELLS; DOCOSAHEXAENOIC ACIDS; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TH1 CELLS; TH17 CELLS;

EID: 79957902911     PISSN: 08891591     EISSN: 10902139     Source Type: Journal    
DOI: 10.1016/j.bbi.2010.09.012     Document Type: Article

References (54)

1. Arita M., Yoshida M., Hong S., Tjonahen E., Glickman J.N., Petasis N.A., Blumberg R.S., Serhan C.N. Resolvin E1, an endogenous lipid mediator derived from omega-3 eicosapentaenoic acid, protects against 2,4,6-trinitrobenzene sulfonic acid-induced colitis. Proc. Natl. Acad. Sci. USA 2005, 102:7671-7676.
2. Attakpa E., Hichami A., Simonin A.M., Sanson E.G., Dramane K.L., Khan N.A. Docosahexaenoic acid modulates the expression of T-bet and GATA-3 transcription factors, independently of PPARalpha, through suppression of MAP kinase activation. Biochimie 2009, 91:1359-1365.
3. Bailes J.E., Mills J.D. Docosahexaenoic acid (DHA) reduces traumatic axonal injury in a rodent head injury model. J. Neurotrauma 2010.
4. Bailey S.L., Schreiner B., McMahon E.J., Miller S.D. CNS myeloid DCs presenting endogenous myelin peptides 'preferentially' polarize CD4+ T(H)-17 cells in relapsing EAE. Nat. Immunol. 2007, 8:172-180.
5. Bannenberg G.L. Resolvins: current understanding and future potential in the control of inflammation. Curr. Opin. Drug Discov. Develop. 2009, 12:644-658.
6. Bazan N.G. Cellular and molecular events mediated by docosahexaenoic acid-derived neuroprotectin D1 signaling in photoreceptor cell survival and brain protection. Prostag. Leukotr. Ess. Fatty Acids 2009, 81:205-211.
7. Beli E., Li M., Cuff C., Pestka J.J. Docosahexaenoic acid-enriched fish oil consumption modulates immunoglobulin responses to and clearance of enteric reovirus infection in mice. J. Nutr. 2008, 138:813-819.
8. Bonilla D.L., Fan Y.Y., Chapkin R.S., McMurray D.N. Transgenic mice enriched in omega-3 fatty acids are more susceptible to pulmonary tuberculosis: impaired resistance to tuberculosis in fat-1 mice. J. Infect. Dis. 2010, 201:399-408.
9. Bousquet M., Saint-Pierre M., Julien C., Salem N., Cicchetti F., Calon F. Beneficial effects of dietary omega-3 polyunsaturated fatty acid on toxin-induced neuronal degeneration in an animal model of Parkinson's disease. FASEB J. 2008, 22:1213-1225.
10. Bouwens M., van de Rest O., Dellschaft N., Bromhaar M.G., de Groot L.C., Geleijnse J.M., Muller M., Afman L.A. Fish-oil supplementation induces antiinflammatory gene expression profiles in human blood mononuclear cells. Am. J. Clin. Nutr. 2009, 90:415-424.
11. Calder P.C. The relationship between the fatty acid composition of immune cells and their function. Prostag. Leukotr. Ess. Fatty Acids 2008, 79:101-108.
12. Calon F., Lim G.P., Yang F., Morihara T., Teter B., Ubeda O., Rostaing P., Triller A., Salem N., Ashe K.H., Frautschy S.A., Cole G.M. Docosahexaenoic acid protects from dendritic pathology in an Alzheimer's disease mouse model. Neuron 2004, 43:633-645.
13. Camuesco D., Galvez J., Nieto A., Comalada M., Rodriguez-Cabezas M.E., Concha A., Xaus J., Zarzuelo A. Dietary olive oil supplemented with fish oil, rich in EPA and DHA (n-3) polyunsaturated fatty acids, attenuates colonic inflammation in rats with DSS-induced colitis. J. Nutr. 2005, 135:687-694.
14. Chapkin R.S., Kim W., Lupton J.R., McMurray D.N. Dietary docosahexaenoic and eicosapentaenoic acid: emerging mediators of inflammation. Prostag. Leukotr. Ess. Fatty Acids 2009, 81:187-191.
15. Das U.N. Essential fatty acids: biochemistry, physiology and pathology. Biotechnol. J. 2006, 1:420-439.
16. Fan Y.Y., Ly L.H., Barhoumi R., McMurray D.N., Chapkin R.S. Dietary docosahexaenoic acid suppresses T cell protein kinase C theta lipid raft recruitment and IL-2 production. J. Immunol. 2004, 173:6151-6160.
17. Frohman E.M., Racke M.K., Raine C.S. Multiple sclerosis - the plaque and its pathogenesis. New Engl. J. Med. 2006, 354:942-955.
18. Gallai V., Sarchielli P., Trequattrini A., Franceschini M., Floridi A., Firenze C., Alberti A., Di Benedetto D., Stragliotto E. Cytokine secretion and eicosanoid production in the peripheral blood mononuclear cells of MS patients undergoing dietary supplementation with n-3 polyunsaturated fatty acids. J. Neuroimmunol. 1995, 56:143-153.
19. Hasturk H., Kantarci A., Goguet-Surmenian E., Blackwood A., Andry C., Serhan C.N., Van Dyke T.E. Resolvin E1 regulates inflammation at the cellular and tissue level and restores tissue homeostasis in vivo. J. Immunol. 2007, 179:7021-7029.
20. Hermann-Kleiter N., Baier G. NFAT pulls the strings during CD4+ T helper cell effector functions. Blood 2010, 115:2989-2997.
21. Hudert C.A., Weylandt K.H., Lu Y., Wang J., Hong S., Dignass A., Serhan C.N., Kang J.X. Transgenic mice rich in endogenous omega-3 fatty acids are protected from colitis. Proc. Natl. Acad. Sci. USA 2006, 103:11276-11281.
22. Insua M.F., Garelli A., Rotstein N.P., German O.L., Arias A., Politi L.E. Cell cycle regulation in retinal progenitors by glia-derived neurotrophic factor and docosahexaenoic acid. Invest. Ophthalmol. Vis. Sci. 2003, 44:2235-2244.
23. Jicha G.A., Markesbery W.R. Omega-3 fatty acids: potential role in the management of early Alzheimer's disease. Clin. Interv. Aging 2010, 5:45-61.
24. Jolly C.A., Jiang Y.H., Chapkin R.S., McMurray D.N. Dietary (n-3) polyunsaturated fatty acids suppress murine lymphoproliferation, interleukin-2 secretion, and the formation of diacylglycerol and ceramide. J. Nutr. 1997, 127:37-43.
25. Kamesaki H., Nishizawa K., Michaud G.Y., Cossman J., Kiyono T. TGF-beta 1 induces the cyclin-dependent kinase inhibitor p27Kip1 mRNA and protein in murine B cells. J. Immunol. 1998, 160:770-777.
26. Katakura M., Hashimoto M., Shahdat H.M., Gamoh S., Okui T., Matsuzaki K., Shido O. Docosahexaenoic acid promotes neuronal differentiation by regulating basic helix-loop-helix transcription factors and cell cycle in neural stem cells. Neuroscience 2009, 160:651-660.
27. Kohli P., Levy B.D. Resolvins and protectins: mediating solutions to inflammation. Br. J. Pharmacol. 2009, 158:960-971.
28. Kong W., Yen J.H., Vassiliou E., Adhikary S., Toscano M.G., Ganea D. Docosahexaenoic acid prevents dendritic cell maturation and in vitro and in vivo expression of the IL-12 cytokine family. Lipids Health Dis. 2010, 9:12.
29. Lecanda J., Ganapathy V., D'Aquino-Ardalan C., Evans B., Cadacio C., Ayala A., Gold L.I. TGFbeta prevents proteasomal degradation of the cyclin-dependent kinase inhibitor p27kip1 for cell cycle arrest. Cell Cycle 2009, 8:742-756.
30. Lloyd R.V., Erickson L.A., Jin L., Kulig E., Qian X., Cheville J.C., Scheithauer B.W. P27kip1: a multifunctional cyclin-dependent kinase inhibitor with prognostic significance in human cancers. Am. J. Pathol. 1999, 154:313-323.
31. Lopez-Vales R., Redensek A., Skinner T.A., Rathore K.I., Ghasemlou N., Wojewodka G., DeSanctis J., Radzioch D., David S. Fenretinide promotes functional recovery and tissue protection after spinal cord contusion injury in mice. J. Neurosci. 2010, 30:3220-3226.
32. Lukiw W.J., Bazan N.G. Inflammatory, apoptotic, and survival gene signaling in Alzheimer's disease. A review on the bioactivity of neuroprotectin D1 and apoptosis. Mol. Neurobiol. 2010, 42:10-16.
33. Marcheselli V.L., Hong S., Lukiw W.J., Tian X.H., Gronert K., Musto A., Hardy M., Gimenez J.M., Chiang N., Serhan C.N., Bazan N.G. Novel docosanoids inhibit brain ischemia-reperfusion-mediated leukocyte infiltration and pro-inflammatory gene expression. J. Biol. Chem. 2003, 278:43807-43817.
34. McFarland C.T., Fan Y.Y., Chapkin R.S., Weeks B.R., McMurray D.N. Dietary polyunsaturated fatty acids modulate resistance to Mycobacterium tuberculosis in guinea pigs. J. Nutr. 2008, 138:2123-2128.
35. Morgan M.E., van Bilsen J.H., Bakker A.M., Heemskerk B., Schilham M.W., Hartgers F.C., Elferink B.G., van der Zanden L., de Vries R.R., Huizinga T.W., Ottenhoff T.H., Toes R.E. Expression of FOXP3 mRNA is not confined to CD4+CD25+ T regulatory cells in humans. Hum. Immunol. 2005, 66:13-20.
36. Ouellet M., Emond V., Chen C.T., Julien C., Bourasset F., Oddo S., LaFerla F., Bazinet R.P., Calon F. Diffusion of docosahexaenoic and eicosapentaenoic acids through the blood-brain barrier: an in situ cerebral perfusion study. Neurochem. Int. 2009, 55:476-482.
37. Palacios-Pelaez R., Lukiw W.J., Bazan N.G. Omega-3 essential fatty acids modulate initiation and progression of neurodegenerative disease. Mol. Neurobiol. 2010, 41:367-374.
38. Schwerbrock N.M., Karlsson E.A., Shi Q., Sheridan P.A., Beck M.A. Fish oil-fed mice have impaired resistance to influenza infection. J. Nutr. 2009, 139:1588-1594.
39. Serhan C.N. Resolution phase of inflammation: novel endogenous anti-inflammatory and proresolving lipid mediators and pathways. Annu. Rev. Immunol. 2007, 25:101-137.
40. Serhan C.N., Chiang N., Van Dyke T.E. Resolving inflammation: dual anti-inflammatory and pro-resolution lipid mediators. Nat. Rev. Immunol. 2008, 8:349-361.
41. Serhan C.N., Yacoubian S., Yang R. Anti-inflammatory and proresolving lipid mediators. Annu. Rev. Pathol. 2008, 3:279-312.
42. Shinto L., Marracci G., Baldauf-Wagner S., Strehlow A., Yadav V., Stuber L., Bourdette D. Omega-3 fatty acid supplementation decreases matrix metalloproteinase-9 production in relapsing-remitting multiple sclerosis. Prostag. Leukotr. Ess. Fatty Acids 2009, 80:131-136.
43. Slavin A., Kelly-Modis L., Labadia M., Ryan K., Brown M.L. Pathogenic mechanisms and experimental models of multiple sclerosis. Autoimmunity 2010.
44. Tiesset H., Pierre M., Desseyn J.L., Guery B., Beermann C., Galabert C., Gottrand F., Husson M.O. Dietary (n-3) polyunsaturated fatty acids affect the kinetics of pro- and antiinflammatory responses in mice with Pseudomonas aeruginosa lung infection. J. Nutr. 2009, 139:82-89.
45. Tran D.Q., Ramsey H., Shevach E.M. Induction of FOXP3 expression in naive human CD4+FOXP3 T cells by T-cell receptor stimulation is transforming growth factor-beta dependent but does not confer a regulatory phenotype. Blood 2007, 110:2983-2990.
46. Tsou S.S., Chiu W.C., Yeh C.L., Hou Y.C., Yeh S.L. Effects of omega-3 fatty acids on inflammatory mediators and splenocyte cytokine mRNA expressions in rats with polymicrobial sepsis. Nutrition 2008, 24:484-491.
47. Wallace F.A., Miles E.A., Evans C., Stock T.E., Yaqoob P., Calder P.C. Dietary fatty acids influence the production of Th1- but not Th2-type cytokines. J. Leukoc. Biol. 2001, 69:449-457.
48. Wang H., Hao Q., Li Q.R., Yan X.W., Ye S., Li Y.S., Li N., Li J.S. Omega-3 polyunsaturated fatty acids affect lipopolysaccharide-induced maturation of dendritic cells through mitogen-activated protein kinases p38. Nutrition 2007, 23:474-482.
49. Weinstock-Guttman B., Baier M., Park Y., Feichter J., Lee-Kwen P., Gallagher E., Venkatraman J., Meksawan K., Deinehert S., Pendergast D., Awad A.B., Ramanathan M., Munschauer F., Rudick R. Low fat dietary intervention with omega-3 fatty acid supplementation in multiple sclerosis patients. Prostag. Leukotr. Ess. Fatty Acids 2005, 73:397-404.
50. Weylandt K.H., Nadolny A., Kahlke L., Kohnke T., Schmocker C., Wang J., Lauwers G.Y., Glickman J.N., Kang J.X. Reduction of inflammation and chronic tissue damage by omega-3 fatty acids in fat-1 transgenic mice with pancreatitis. Biochim. Biophys. Acta 2008, 1782:634-641.
51. Yessoufou A., Ple A., Moutairou K., Hichami A., Khan N.A. Docosahexaenoic acid reduces suppressive and migratory functions of CD4+CD25+ regulatory T-cells. J. Lipid Res. 2009, 50:2377-2388.
52. Zapata-Gonzalez F., Rueda F., Petriz J., Domingo P., Villarroya F., Diaz-Delfin J., de Madariaga M.A., Domingo J.C. Human dendritic cell activities are modulated by the omega-3 fatty acid, docosahexaenoic acid, mainly through PPAR(gamma):RXR heterodimers: comparison with other polyunsaturated fatty acids. J. Leukoc. Biol. 2008, 84:1172-1182.
53. Zeyda M., Saemann M.D., Stuhlmeier K.M., Mascher D.G., Nowotny P.N., Zlabinger G.J., Waldhausl W., Stulnig T.M. Polyunsaturated fatty acids block dendritic cell activation and function independently of NF-kappaB activation. J. Biol. Chem. 2005, 280:14293-14301.
54. Zhang F., Meng G., Strober W. Interactions among the transcription factors Runx1, RORgammat and Foxp3 regulate the differentiation of interleukin 17-producing T cells. Nat. Immunol. 2008, 9:1297-1306.